SA

Sameer Ahmad Bhat

Director Director DIN 08512660
DIN 08512660 First appointment Jul 2019 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2019
Shareholding value Locked Premium profile

About Sameer Ahmad Bhat

Sameer Ahmad Bhat has 7 years in corporate governance. Formerly with 1 company, such as Spenduo Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08512660
Primary Designation Director
First Appointment 17 Jul 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Director 17 Jul 2019 2019 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Spenduo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sameer Ahmad Bhat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sameer Ahmad Bhat

Sameer Ahmad Bhat has 7 years in corporate governance. Formerly with 1 company, such as Spenduo Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Sameer Ahmad Bhat is associated with 0 companies as a director.

Sameer Ahmad Bhat has expertise in General Business.

Sameer Ahmad Bhat has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available